Inna Vainshtein

Executive Director, Bioanalysis Exelixis, Inc.

Seminars

Monday 3rd November 2025
Developing LBA & Hybrid-LCMS Bioanalytical Methods to Evaluate ADC PK ADC in Non-Clinical Studies & Assessment of In Vitro Stability
11:30 am
  • Presenting LBA-based PK methods for ADC bioanalysis in early non-clinical studies
  • Discussing transition of ADC PK methods to hybrid-LCMS in following non-clinical studies to align with clinical PK methods
  • Demonstrating the use of bioanalytical methods to assess ADC in vitro stability
Inna Vainshtein - 16th World ADC San Diego